Novlead Overview
- Founded
- 2018
- Status
- Private
- Latest Deal Type
- Series B
- Latest Deal Amount
- $18.7M
- Investors
- 4
Novlead General Information
Description
Developer and manufacturer of medical devices. The company focuses on the medical application of nitric oxide (NO) to treat pulmonary hypertension and infectious diseases, improving the treatment efficiency and the quality of patients life.
Contact Information
Website
www.novlead.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Primary Office
- C1-2,Building16,Treehouse
- 73Tanmi Road, Jiangbei New District
- Nanjing, Jiangsu 211800
- China
+86 025 0000 0000
Novlead Timeline
Novlead Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series B) | 15-Nov-2021 | $18.7M | 000.00 | Completed | Generating Revenue | |
| 2. Early Stage VC (Series A) | 19-Dec-2020 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 26-Apr-2020 | Completed | Generating Revenue |
Novlead Executive Team (5)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Wen Mao Ph.D | Chief Executive Officer | ||
| Yufeng Wu | Chief Operating Officer | ||
| Yu Qin Ph.D | CSO | ||
| Yuyan Zhang | CTO |
Novlead Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| 3E Bioventures Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Lilly Asia Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Northern Light Venture Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| InnoMed Capital | Venture Capital | Minority | 000 0000 | 000000 0 |